Green Thumb Industries (GTI) to Open Rise Hermitage, the Seventh Rise(TM) Cannabis Store in Pennsylvania, on September 19
Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise(TM) and Essence retail stores, today announced it will open Rise Hermitage, the seventh Rise(TM) retail location in Pennsylvania, on September 19.
Green Thumb Industries (GTI) Announces Conference Participation for September 2019
Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of the Rise(TM) and Essence retail stores, today announced that its executive team will participate in the following conferences in September 2019:
Demand for Craft Cannabis Swells as Medical Patients Look for Alternative Treatments
The burden of dealing with symptoms associated with medical conditions has financially and physically ravaged millions of people around the globe. Every day, people suffering from medical conditions are distraught by the harsh effects of the symptoms derived from their ailments. For instance, patients receiving cancer therapy can face a plethora of side effects such as nausea and severe pain. Generally, patients take a plethora of medicines in order to subdue these side effects, and in particular, cancer patients suffering from chronic pain may be prescribed dangerous opioids from their physician. As a result, more medical institutions are beginning to recommend cannabis as an alternative to treat the adverse conditions associated with cancer. The American Cancer Society has even cited studies that determined that marijuana can be helpful in treating the side effects of cancer chemotherapy. A few studies have even uncovered that inhaled (smoked or vaporized) marijuana can help with the treatment of neuropathic pain. And more recently, scientists have also reported that THC and other cannabinoids such as CBD can slow the growth of and possibly even eliminate cancer cells, ultimately reducing the spread of certain forms of cancer. Other studies have also suggested that cannabinoids can be safe for humans in treating cancer, which has led to the widespread use of medical cannabis around the world. Now, as more global government agencies collect positive data from clinical trials, additional nations will move towards legalizing medical cannabis because of its potentially valuable therapeutic effects. And as a result, the global legal marijuana market is expected to reach USD 146.4 Billion by 2025 while registering a CAGR of 34.6%, according to data compiled by Grand View Research. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), Sundial Growers Inc. (NASDAQ: SNDL), Aphria Inc. (NYSE: APHA) (TSX: APHA), HEXO Corp. (NYSE: HEXO) (TSX: HEXO), Green Thumb Industries Inc. (OTC: GTBIF) (CSE: GTII)